IDXG — Interpace Biosciences Share News
0.000.00%
Last trade - 00:00- $29.92m
- $27.23m
- $38.73m
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million
Interpace Biosciences' Q4 revenue falls 26% after PancraGEN discontinuation
Brief: Interpace Biosciences Q4 Revenue USD 9.224 Million
Interpace Biosciences Q3 revenue down
Brief: Interpace Biosciences Q3 Revenue USD 8.756 Million
Brief: Interpace Biosciences Q2 Revenue USD 9.232 Million
Brief: Interpace Biosciences Q1 Revenue USD 11.515 Million
Brief: Interpace Biosciences Q3 Revenue USD 12.295 Million
Brief: Interpace Biosciences Q2 Revenue USD 12.001 Million
Brief: Interpace Biosciences Q1 Revenue USD 10.273 Million
Brief: Interpace Biosciences Q4 Revenue USD 10.283 Million
Brief: Interpace Biosciences Q3 Revenue USD 9.078 Million
Brief: Interpace Biosciences Q2 Revenue USD 11.026 Million
Brief: Interpace Biosciences Announces Record First Quarter 2023 Financial And Business Results
Brief: Interpace Biosciences Announces Third Quarter 2022 Financial, Business Results
Brief: Interpace Biosciences Announces Q1 2022 Financial And Business Results